Plant sterol · Phytosterol · 4-desmethylsterols
60 mg · vegan · gluten-free · 60 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Beta-sitosterol is a plant sterol structurally similar to cholesterol, found in nuts, seeds, fruits, and vegetables. As a concentrated supplement, it is one of the most evidence-backed phytochemicals for reducing lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH).
Beta-sitosterol appears to inhibit 5-alpha-reductase and reduce inflammation within prostatic tissue. It may also modulate prostate cell growth and improve bladder contractility. Unlike saw palmetto, its clinical evidence comes from trials using the isolated compound rather than complex herbal mixtures.
Men with mild-to-moderate BPH symptoms seeking a botanical option with relatively strong RCT support. Also relevant for men interested in modest cholesterol management, though doses for that purpose are higher (2 g/day).
Avoid if you have sitosterolemia (a rare genetic phytosterol storage disorder). High doses may reduce absorption of fat-soluble vitamins (A, D, E, K). Not a substitute for urological care if symptoms are severe.
Pick a depth — minimum to maximal coverage
No full stack configured.
Click individual supplement pills above to buy each on Amazon India.
✓ Timing is flexible; consistency matters more than clock time
✓ Timing is flexible; consistency matters more than clock time
✓ Take with meals to enhance absorption and reduce GI upset
Beta-sitosterol appears to inhibit 5-alpha-reductase and reduce inflammation within prostatic tissue.
Each bar = one cited trial. Effect varies by methodology, dose, and population.
Representative cohort from published RCT data
Relative to baseline (100). Data from published clinical literature.
200
→ Double-blind RCT: beta-sitosterol significantly improved IPSS scores and urinary flow rate versus placebo over 6 months in 200 men.
177
→ Multicenter RCT confirmed significant improvements in IPSS, urinary flow, and residual urine volume versus placebo.
200
→ 18-month follow-up of the original Lancet cohort showed sustained IPSS and flow rate benefits without significant side effects.
B · Among prostate botanicals, beta-sitosterol has the most consistent RCT evidence. Two well-designed double-blind trials (Berges 1995, Klippel 1997) and an 18-month follow-up support symptom improvement. However, no trial has demonstrated prostate volume reduction or prevention of disease progression.
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: See richResearch section for study filters and participant data. Clinical evidence summarised from peer-reviewed journals.
How to use Beta-Sitosterol specifically for Frequent urination — the right dose, timing, blood markers to track, and how to know if it is working.
A clinical evidence review of Beta-Sitosterol — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Everything you need to know about Beta-Sitosterol — mechanism, dose, safety, buying guide for India, and what the research actually says.
SacredBod's longer take on Beta-Sitosterol — context the structured blocks above don't capture.
Beta-sitosterol stands out in the crowded field of prostate supplements because it has something most competitors lack: multiple well-controlled human trials showing consistent, if modest, symptom improvement. For men skeptical of herbal hype, it offers a relatively grounded starting point.
The landmark study (Berges et al., 1995) randomized 200 men to either 20 mg beta-sitosterol three times daily or placebo for 6 months. The treatment group achieved a statistically significant improvement in IPSS scores and peak urinary flow rate compared with placebo. Importantly, this was a double-blind, placebo-controlled design — the gold standard for evaluating symptom-based outcomes.
A 1997 multicenter trial (Klippel et al.) replicated these findings in 177 men using a different beta-sitosterol preparation, again demonstrating significant improvements in IPSS, flow rate, and residual urine volume. The consistency across independent trials strengthens confidence in the effect.
The 18-month follow-up (Berges et al., 2000) tracked the original cohort and found that benefits persisted over the longer term without significant adverse effects. This addresses one common criticism of BPH supplements — that any benefit is short-lived.
Despite its symptomatic benefits, beta-sitosterol has not been shown to shrink the prostate gland, lower PSA, or reduce the risk of acute urinary retention or surgery. It is a symptom-modifying agent, not a disease-modifying one. Men with rapidly worsening symptoms, elevated PSA, or confirmed prostate enlargement on imaging should not rely on beta-sitosterol as monotherapy.
Beta-sitosterol is one of several plant sterols; campesterol and stigmasterol are chemically similar but less studied for prostate health. Clinical trials used purified beta-sitosterol at doses of 60-130 mg/day, not the trace amounts found in saw palmetto or pygeum complex products. If you are taking a “prostate complex” capsule, check the label — many contain negligible amounts of actual beta-sitosterol.
At doses of 2 g/day, beta-sitosterol is an FDA-recognized cholesterol-lowering agent. The 60-130 mg doses used for BPH are unlikely to produce meaningful lipid changes. Conversely, cholesterol-lowering doses may cause GI side effects and interfere with fat-soluble vitamin absorption.
Among the “big three” prostate botanicals — saw palmetto, pygeum, and beta-sitosterol — beta-sitosterol has the most consistent human evidence for symptom relief. Nettle root also has plausible mechanisms (SHBG modulation, aromatase inhibition) but weaker clinical trial support. For men building a layered prostate stack, beta-sitosterol is the most defensible first ingredient.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
